MarginsXMarginsX
Home › Markets › Health Care › INSP

Inspire Medical Systems Inc. (INSP)

INSP trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$59.12
-3.24% on the day
Market cap
$1.7B
Small cap
Revenue · 2025
$912.0M
+13.6% on 2024
Net income · 2025
$145.4M
15.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1609550/000160955026000016/0001609550-26-000016-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerINSP on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2018
SEC CIK0001609550
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$912.0M
Net income$145.4M
Operating income$51.0M
Net margin15.9%
Operating margin5.6%
Revenue growth+13.6%
Cash$104.8M
Total assets$907.3M
P/E (computed)11.8×
P/S (computed)1.9×

Warning signs

Cash runway
Cash-flow positive
$190.8M cash at September 30, 2026
Share count, 1 year
-0.3%
2025-10-29 to 2026-10-28 · -1.9% over 3 years
Going-concern doubt
No
10-Q filed November 2, 2026
Insider net buying, 12 months
-$666K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-02
Cash and burn$190.8M cash; operating cash flow $33.7M a quarter.Report 2026-09-30
Shares outstanding28,966,119 (2026-10-28); 29,056,434 a year earlier; 29,524,189 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $666K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$206.7M-$24.4M$46.4M$190.8MNo debt tags$880.9M10-Q 2026-11-02
Q2 2026
2026-06-30
$200.6M$314K$23.2M$127.8MNo debt tags$898.7M10-Q 2026-08-03
Q1 2026
2026-03-31
$204.6M-$11.3M$12.8M$98.9MNo debt tags$915.2M10-Q 2026-05-04
Q4 2025
2025-12-31
$269.1M$136.1M$52.5M$104.8MNo debt tags$912.0M10-K 2026-02-13
Q3 2025
2025-09-30
$224.5M$9.9M$68.5M$112.8MNo debt tags$882.6M10-Q 2026-11-02
Q2 2025
2025-06-30
$217.1M-$3.6M$2.7M$106.9MNo debt tags$861.3M10-Q 2026-08-03
Q1 2025
2025-03-31
$201.3M$3.0M-$6.7M$53.9MNo debt tags$840.1M10-Q 2026-05-04
Q4 2024
2024-12-31
$239.7M$35.2M$69.2M$150.2MNo debt tags$802.8M10-K 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52022-08-15
Latest annual report10-K2026-02-13
Latest quarterly / interim10-Q2026-11-02
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-03-20

Source: SEC EDGAR submissions feed, 900 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.5%
1 month-11.3%
3 months+5.0%
Year to date-33.8%
1 year-29.6%
From 52-week high-57.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
KMTSKestra Medical Technologies Ltd.$27.97-2.34%$1.7B
LMATLeMaitre Vascular Inc.$77.01-1.63%$1.8B
XRAYDENTSPLY SIRONA Inc.$8.95-2.35%$1.8B
PRCTPROCEPT BioRobotics Corporation$23.54-1.09%$1.4B
NVCRNovoCure Limited$11.30-4.48%$1.3B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
UFPTUFP Technologies Inc.$298.54-2.14%$2.3B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier